Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression

Journal of Immunology

Volumn 167, Issue 2, 2001, Pages 1103-1111

  Adams, A B ^a   Durham, M M ^a   Kean, L ^a   Shirasugi, N ^a   Ha, J ^a   Williams, M A ^a   Rees, P A ^a   Cheung, M C ^a   Mittelstaedt, S ^a   Bingaman, A W ^a   Archer, D R ^a   Pearson, T C ^a   Waller, E K ^a   Larsen, C P ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; GAMMA INTERFERON;

ALLOGRAFT; ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA THALASSEMIA; BONE MARROW SUPPRESSION; CELL COMPARTMENTALIZATION; CHIMERA; CONTROLLED STUDY; DOSE RESPONSE; GAMMA IRRADIATION; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMOGLOBINOPATHY; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE DEPLETION; MALE; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0035879193     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.2.1103     Document Type: Article

References (25)

1. Immunogenetic consequences of vascular anastomoses between bovine twins
2. Actively acquired tolerance of foreign cells
3. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: Long-term survival of allogeneic bone marrow and skin grafts
4. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts
5. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen
6. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen
7. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning
8. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance
9. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment
10. Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning
11. HL-A-identical marrow transplants in aplastic anemia, acute leukemia, and lymphosarcoma employing cyclophosphamide
12. Growth of human hematopoietic cells in immunodeficient mice conditioned with cyclophosphamide and busulfan
13. The role of busulfan/cyclophosphamide regimens in allogeneic and autologous bone marrow transplantation
14. Simplified typing of mouse hemoglobin (Hbb) phenotypes using cystamine
15. Growth retardation and depigmentation of hair after high-dose busulfan and congenic hematopoietic cell transplantation in mice
16. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients
17. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor-specific unresponsiveness in the murine model
18. + T cells, interferon-γ, and CTLA4
19. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow
20. Lethal thalassemia after insertional disruption of the mouse major adult β-globin gene
21. + T cell tolerance and linked suppression
22. Genes encoding ligands for deletion of VB11 T cells cosegregate with mammary turnout virus genomes
23. The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V β 11-bearing T cells
24. Determination of lymphocyte division by flow cytometry
25. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide